Table 2 Outcome measures
Variables | Propensity score-matched cohort | Entire cohort | ||||
|---|---|---|---|---|---|---|
Rehospitalized patients | Rehospitalized patients | |||||
User (N = 24) | Non-user (N = 43) | P value | User (N = 44) | Non-user (N = 73) | P value | |
BNP value at rehospitalization (pg/ml) | 763 (516–1428) | 628 (435–1502) | 0.707 | 984 (512–1493) | 680 (376–1580) | 0.403 |
The maximum daily dose of intravenous furosemide (mg) | 15 (10–35) | 10 (0–25) | 0.275 | 20 (10–40) | 10 (0–40) | 0.192 |
Patients requiring intravenous inotropes, n (%) | 13 (30%) | 21 (29%) | 1.000 | 13 (30%) | 21 (29%) | 1.000 |
The length of rehospitalization (day) | 15.5 (12.3–26) | 15 (11–27) | 0.958 | 14.5 (12–25.3) | 19 (13–34) | 0.242 |
In-hospital mortality, n (%) | 1 (4.2%) | 4 (9.3%) | 0.647 | 3 (6.8%) | 7 (9.6%) | 0.741 |